184 related articles for article (PubMed ID: 32572850)
21. Next generation sequencing of extraskeletal myxoid chondrosarcoma.
Davis EJ; Wu YM; Robinson D; Schuetze SM; Baker LH; Athanikar J; Cao X; Kunju LP; Chinnaiyan AM; Chugh R
Oncotarget; 2017 Mar; 8(13):21770-21777. PubMed ID: 28423517
[TBL] [Abstract][Full Text] [Related]
22. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
[TBL] [Abstract][Full Text] [Related]
23. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.
Urbini M; Indio V; Astolfi A; Tarantino G; Renne SL; Pilotti S; Dei Tos AP; Maestro R; Collini P; Nannini M; Saponara M; Murrone L; Dagrada GP; Colombo C; Gronchi A; Pession A; Casali PG; Stacchiotti S; Pantaleo MA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937513
[TBL] [Abstract][Full Text] [Related]
24. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Stacchiotti S; Ferrari S; Redondo A; Hindi N; Palmerini E; Vaz Salgado MA; Frezza AM; Casali PG; Gutierrez A; Lopez-Pousa A; Grignani G; Italiano A; LeCesne A; Dumont S; Blay JY; Penel N; Bernabeu D; de Alava E; Karanian M; Morosi C; Brich S; Dagrada GP; Vallacchi V; Castelli C; Brenca M; Racanelli D; Maestro R; Collini P; Cruz J; Martin-Broto J
Lancet Oncol; 2019 Sep; 20(9):1252-1262. PubMed ID: 31331701
[TBL] [Abstract][Full Text] [Related]
25. Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma.
Filion C; Labelle Y
Tumour Biol; 2012 Oct; 33(5):1599-605. PubMed ID: 22592656
[TBL] [Abstract][Full Text] [Related]
26. Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival.
Brown JM; Rakoczy K; Pretell-Mazzini J
Cancer Treat Res Commun; 2022; 31():100530. PubMed ID: 35144048
[TBL] [Abstract][Full Text] [Related]
27. TAF15::NR4A3 gene fusion identifies a morphologically distinct subset of extraskeletal myxoid chondrosarcoma mimicking myoepithelial tumors.
Warmke LM; Wang WL; Baumhoer D; Andrei V; Ameline B; Baker ML; Kerr DA
Genes Chromosomes Cancer; 2023 Oct; 62(10):581-588. PubMed ID: 37057757
[TBL] [Abstract][Full Text] [Related]
28. Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management.
Stacchiotti S; Baldi GG; Morosi C; Gronchi A; Maestro R
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967265
[TBL] [Abstract][Full Text] [Related]
29. CHRNA6 RNA In Situ Hybridization Is a Useful Tool for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.
Dulken BW; Kingsley L; Zdravkovic S; Cespedes O; Qian X; Suster DI; Charville GW
Mod Pathol; 2024 May; 37(5):100464. PubMed ID: 38447752
[TBL] [Abstract][Full Text] [Related]
30. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.
Bishop AJ; Bird JE; Conley AP; Roland CL; Moon BS; Satcher RL; Livingston JA; Patel S; Wang WL; Lazar AJ; Lewis VO; Lin PP; Guadagnolo BA
Am J Clin Oncol; 2019 Oct; 42(10):744-748. PubMed ID: 31436747
[TBL] [Abstract][Full Text] [Related]
31. Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up.
Ogura K; Fujiwara T; Beppu Y; Chuman H; Yoshida A; Kawano H; Kawai A
Arch Orthop Trauma Surg; 2012 Oct; 132(10):1379-86. PubMed ID: 22678528
[TBL] [Abstract][Full Text] [Related]
32. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract][Full Text] [Related]
33. Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models.
Bangerter JL; Harnisch KJ; Chen Y; Hagedorn C; Planas-Paz L; Pauli C
Hum Cell; 2023 Jan; 36(1):446-455. PubMed ID: 36316541
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary extraskeletal myxoid chondrosarcoma: A case report and literature review.
Balanzá R; Arrangoiz R; Cordera F; Muñoz M; Luque-de-León E; Moreno E; Molinar L; Somerville N
Int J Surg Case Rep; 2016; 27():96-101. PubMed ID: 27591381
[TBL] [Abstract][Full Text] [Related]
35. Periosteal Myxoid Leiomyosarcoma Histologically Mimicking Extraskeletal Myxoid Chondrosarcoma: Report of a Case with Histopathological and Cytopathological Comparison with Extraskeletal Myxoid Chondrosarcoma.
Kikuchi Y; Watabe S; Yamamoto A; Sato K; Fujinuma W; Kawano J; Yuzawa K; Aso T; Eguchi M; Ishida T; Motoi T; Uozaki H
Acta Cytol; 2021; 65(6):541-548. PubMed ID: 34569497
[TBL] [Abstract][Full Text] [Related]
36. Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions.
Chiusole B; Le Cesne A; Rastrelli M; Maruzzo M; Lorenzi M; Cappellesso R; Del Fiore P; Imbevaro S; Sbaraglia M; Terrier P; Ruggieri P; Dei Tos AP; Rossi CR; Zagonel V; Brunello A
Front Oncol; 2020; 10():828. PubMed ID: 32612944
[No Abstract] [Full Text] [Related]
37. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases.
Meis-Kindblom JM; Bergh P; Gunterberg B; Kindblom LG
Am J Surg Pathol; 1999 Jun; 23(6):636-50. PubMed ID: 10366145
[TBL] [Abstract][Full Text] [Related]
38. Surgical outcomes of extraskeletal myxoid chondrosarcoma.
Ulucaköy C; Atalay İB; Yapar A; Kaptan AY; Bingöl İ; Doğan M; Ekşioğlu MF
Turk J Med Sci; 2022 Aug; 52(4):1183-1189. PubMed ID: 36326382
[TBL] [Abstract][Full Text] [Related]
39. Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour.
Sugino H; Iwata S; Satomi K; Mori T; Nobusawa S; Nagashima T; Matsushita Y; Yatabe Y; Ichimura K; Kawai A; Yoshida A
Histopathology; 2023 May; 82(6):937-945. PubMed ID: 36754860
[TBL] [Abstract][Full Text] [Related]
40. NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma.
Flucke U; Tops BB; Verdijk MA; van Cleef PJ; van Zwam PH; Slootweg PJ; Bovée JV; Riedl RG; Creytens DH; Suurmeijer AJ; Mentzel T
Virchows Arch; 2012 Jun; 460(6):621-8. PubMed ID: 22569967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
